![Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-022-01273-8/MediaObjects/41392_2022_1273_Fig1_HTML.png)
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
![Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition](https://jn.nutrition.org/cms/asset/c69881dc-fa50-40ea-b6e1-707bfe9e469a/gr1.jpg)
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition
![Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40035-022-00296-z/MediaObjects/40035_2022_296_Fig1_HTML.png)
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
![The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology](https://www.thelancet.com/cms/asset/ddb9b657-b357-41f8-bc42-c596461297b4/gr1.jpg)
The complex pathway between amyloid β and cognition: implications for therapy - The Lancet Neurology
![Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 - Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -](https://onlinelibrary.wiley.com/cms/asset/d216ecae-fcef-4161-a376-adb04afe7688/jnc13037-fig-0007-m.jpg)
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre‐clinical AD, amnestic mild cognitive impairment and late‐stage AD - Tramutola - 2015 -
![Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-023-01484-7/MediaObjects/41392_2023_1484_Fig1_HTML.png)
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
![Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.3c04855/asset/images/large/ao3c04855_0004.jpeg)
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer's Disease | ACS Omega
![Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1568163721002439-ga1.jpg)
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
![Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS](https://www.pnas.org/cms/asset/4909b395-85d6-483b-8c88-f4372f193353/keyimage.jpg)
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
![IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease](https://www.mdpi.com/ijms/ijms-24-08976/article_deploy/html/images/ijms-24-08976-g001.png)
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
![Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients](https://www.frontiersin.org/files/Articles/568023/fnagi-12-00272-HTML/image_m/fnagi-12-00272-g001.jpg)
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
![Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers](https://pub.mdpi-res.com/biomedicines/biomedicines-10-00850/article_deploy/html/images/biomedicines-10-00850-g001.png?1649153798)
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
![Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/83de9bd8-e2bd-4e61-8d2b-eebfe7746175/jnc15030-fig-0004-m.png)
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
![SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/f495e754-ac3d-4a88-821d-540547ce56d2/fx1_lrg.jpg)
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
![Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124722012281-fx1.jpg)
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
![JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment](https://pub.mdpi-res.com/jcm/jcm-12-04298/article_deploy/html/images/jcm-12-04298-ag.png?1689225167)
JCM | Free Full-Text | Investigating the Prognostic Role of Peripheral Inflammatory Markers in Mild Cognitive Impairment
![Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13195-020-00738-8/MediaObjects/13195_2020_738_Fig1_HTML.png)